Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DMI Life Sciences
AddedMar 20, 2024
UpdatedJun 18, 2026
DMI Life Sciences

DMI Life Sciences

Inactive

Innovative biotech targeting inflammation in diseases. Founded in 2009. HQ in Greenwood Village, CO.

HQ
Greenwood Village, CO, US
Founded
2009
Overview
Compare
Fundraising
Employees

DMI Life Sciences is a biotechnology company dedicated to discovering and developing small molecule and peptide-based pharmaceuticals and biomarkers for acute and chronic inflammation. The company targets immunologic, vascular, and CNS diseases, including acute coronary syndrome, multiple sclerosis, Alzheimer’s disease, asthma, and cancer. Founded by David Bar and Michael Macaluso in 2009, DMI Life Sciences is headquartered in Greenwood Village, Colorado.

DMI Life Sciences has made significant strides in the biotech industry by focusing on innovative treatments for inflammation-related diseases. Their research and development efforts have contributed to advancements in understanding and managing complex conditions, impacting patient care and treatment outcomes.

DMI Life Sciences - Similar Companies

Dianomi Therapeutics logo

Dianomi Therapeutics

Imidomics logo

Imidomics

imidomics.com

ISI Life Sciences logo

ISI Life Sciences

Diamir logo

Diamir

diamirbio.com

Kezar Life Sciences logo

Kezar Life Sciences

Inflammasome Therapeutics logo

Inflammasome Therapeutics

inflam.com

BioHealthonomics logo

BioHealthonomics

DecImmune Therapeutics logo

DecImmune Therapeutics

decimmune.com

Biomarck Pharmaceuticals logo

Biomarck Pharmaceuticals

Intellimedix logo

Intellimedix

Tesla Life Sciences logo

Tesla Life Sciences

Diomics logo

Diomics

Ampere Life Sciences logo

Ampere Life Sciences

HI-Bio logo

HI-Bio

hibio.com

Neumedics logo

Neumedics

DMI Life Sciences - Quick Facts

Who are DMI Life Sciences' competitors?

Companies similar to DMI Life Sciences include Dianomi Therapeutics, Imidomics, ISI Life Sciences and Diamir.

When was DMI Life Sciences founded?

DMI Life Sciences was founded in 2009.

Where is DMI Life Sciences' headquarters located?

DMI Life Sciences' headquarters is located in Greenwood Village, CO, US.

When was DMI Life Sciences' last funding round?

DMI Life Sciences' most recent funding round was for $1.2M (USD) in April 2009.

How much has DMI Life Sciences raised to-date?

As of Apr 16, 2009, DMI Life Sciences has raised a total of $1.2M (USD).

DMI Life Sciences - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biomarkers
  • Pharmaceuticals
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified